20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants

Completed · Phase 3

Conditions studied: Pneumococcal Disease

In brief

This study is designed to evaluate the safety and tolerability of 20vPnC in healthy infants.

Key facts

Study ID
NCT04379713
Run by
Pfizer
People needed
1511
Starts
2020-05-21
Expected to finish
2022-08-31
Last updated by the study team
2023-06-13

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.